HSBC/CALL/PFIZER INC/65/0.1/18.12.24 Share Price

Warrant

DE000HG6S393

Real-time BOERSE MUENCHEN 20:37:01 28/05/2024 BST
0.011 EUR 0.00% Intraday chart for HSBC/CALL/PFIZER INC/65/0.1/18.12.24
Date Price Change
28/05/24 0.011 0.00%
27/05/24 0.011 0.00%
24/05/24 0.011 0.00%
23/05/24 0.011 0.00%
22/05/24 0.011 0.00%

Real-time BOERSE MUENCHEN

Last update May 28, 2024 at 08:37 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer HSBC
WKN HG6S39
ISINDE000HG6S393
Date issued 08/11/2022
Strike 65 $
Maturity 18/12/2024 (204 Days)
Parity 10 : 1
Emission price 0.3
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.45
Lowest since issue 0.011
Delta0.02x
Omega 8.213
Premium130.85x
Gearing432.68x
Moneyness 0.4336
Difference Strike 36.7 $
Difference Strike %+56.46%
Spread 0.01
Spread %90.91%
Theoretical value 0.006000
Implied Volatility 49.27 %
Total Loss Probability 99.26 %
Intrinsic value 0.000000
Present value 0.006000
Break even 65.07 €
Theta-0x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.88 USD
Average target price
31.92 USD
Spread / Average Target
+10.51%
Consensus